The compounds presented are investigational or are being investigated for uses that have not been approved by the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities.
AUA 2025
Abstracts Sponsored by Bayer
April 26-29, 2025
Agenda of oral and poster presentations at the 2025 American Urological Association (AUA) Annual Meeting
Please see below to download a PDF for each presentation and view a video (where applicable). Access for each publication will be available after the congress presentation.
Please select a compound to navigate to all related publications.
NUBEQA
Ultra-low PSA Response (<0.02 ng/mL) With Darolutamide Plus ADT in ARANOTE Correlates With Greatly Improved Clinical Outcomes
Date/Time:
Tuesday, April 29, 2025 | 9:30 AM – 11:30 AM PST
Session:
Prostate Cancer: Advanced (including Drug Therapy) III
Type:
Interactive Poster Session
Presenting Author:
Neal Shore
Poster Bd #:
IP26-07
Efficacy and Safety of Darolutamide Plus Androgen-Deprivation Therapy (ADT) in Black Patients With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) from the Phase 3 ARANOTE Trial
Date/Time:
Sunday, April 27, 2025 | 1:00 PM – 3:00 PM PST
Session:
Prostate Cancer: Advanced (including Drug Therapy) II
Type:
Moderated Poster Session
Presenting Author:
Quoc-Dien Trinh
Poster Bd #:
MP16-01
Long-Term Safety and Tolerability of Extended Treatment with Darolutamide in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Insights from ARASENS Rollover Study
Date/Time:
Tuesday, April 29, 2025 | 9:30 AM – 11:30 AM PST
Session:
Prostate Cancer: Advanced (including Drug Therapy) III
Type:
Interactive Poster Session
Presenting Author:
Neal Shore
Poster Bd #:
IP26-06
Prespecified Third Interim Analysis of the Darolutamide Observational (DAROL) Study in Patients with Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): North American (NAm) Subgroup Analysis
Date/Time:
Tuesday, April 29, 2025 | 9:30 AM – 11:30 AM PST
Session:
Prostate Cancer: Advanced (including Drug Therapy) III
Type:
Interactive Poster Session
Presenting Author:
Christopher Pieczonka
Poster Bd #:
IP26-25
Challenges and unmet needs of caregivers for patients with prostate cancer: A US-based quantitative survey
Date/Time:
Saturday, April 26, 2025 | 9:30 AM – 11:30 AM PST
Session:
Health Services Research: Practice Patterns, Quality of Life and Shared Decision Making I
Type:
Interactive Poster Session
Presenting Author:
Zachary Klaassen
Poster Bd #:
IP04-31
Darolutamide plus androgen-deprivation therapy (ADT) in patients with high-risk biochemical recurrence (BCR) of prostate cancer: A phase 3, randomized, double-blind, placebo-controlled study (ARASTEP)
Date/Time:
Monday, April 28, 2025 | 2:44 PM – 2:52 PM PST
Session:
Clinical Trials in Progress: Prostate & Kidney Cancer
Type:
Oral
Presenting Author:
Neal Shore
Presentation #:
-
